Another study, IMpower 130, evaluated the therapeutic effects of platinum‐based chemotherapy in combination with atezolizumab, an anti‐PD‐L1 antibody, in advanced nonsquamous NSCLC. Here, CD274 is linked to non-small cell lung carcinoma.